IBD Medication Guide

Go
Golimumab
Go

Golimumab

Brand Name(s)

SimponiĀ®

Drug Class

Biologics

How taken

Injection under the skin (subcutaneous)

Used for

Moderate-to-severe ulcerative colitis

Recommendations for Pregnancy

No proven risk in humans

Recommendations for Lactation

No human data: probably compatible

Medication indication

Induces and maintains a clinical response in patients with moderate to severe active ulcerative colitis when certain other medications have not worked well enough or cannot be tolerated, or if it is necessary to continue taking steroid medications.

Indicated for pediatric use

NOTE: This medication may be recommended for use in children. Be sure to talk to your doctor about potential risks and side effects.

Most common side effects

Upper respiratory infection such as runny nose, sore throat, hoarseness or laryngitis; injection site reactions such as redness, swelling, itching, pain, bruising and tingling; viral infections such as flu and oral cold sores.

Other

There have been reports of serious infections while taking golimumab, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that spread throughout the body. Lymphoma and other malignancies have been reported in children and adolescent patients treated with TNF blockers, of which golimumab is a member.

To see the full prescribing information for this medication, click here.

Learn more about biologics

Scroll right by clicking & dragging with your cursor or swiping with your finger.